Agilent Technologies Introduces New External Valve Oven for Gas Chromatograph
January 8, 2014
SANTA CLARA, Calif.-- Agilent Technologies Inc. (NYSE: A) today announced the availability of the Agilent Large Valve Oven for the 7890B gas chromatograph (GC) system. This versatile, high-capacity external oven can be configured to support complex, multi-valve ASTM International and EN (European Standard) GC applications. Precisely engineered for thermal isolation from the GC oven, the [...]
2013 SALES: UP 13% TO €10 MILLION
January 8, 2014
PARIS– Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market, just released its consolidated sales figures for the year ended December 31, 2013. Sacha Loiseau, CEO of Mauna Kea Technologies, made the following comment: "Fourth quarter sales are in line with those of the previous year. The sales trend in the [...]
ProteinSimple Launches Low-Cost Simple Western
January 8, 2014
SANTA CLARA, Calif. -- ProteinSimple today introduced Wes, another revolutionary re-invention of the Western blot. Wes is the bold evolution of the popular Simple Western family of instruments, delivering simplicity and performance like no product before it. With just 30 minutes of sample prep, Wes will analyze up to 25 samples in under 3 hours [...]
SEQUENOM ANNOUNCES ISSUANCE OF EUROPEAN PATENT FOR NOVEL METHODS OF DETECTING FETAL ANEUPLOIDY
January 8, 2014
SAN DIEGO -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced that on January 1, 2014, the European Patent Office (EPO) issued patent EP2183693 B1, entitled "Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing," invented by Drs. Dennis Lo, Rossa Chiu, and Kwan Chee Chan of The [...]
Spinomix announces a milestone payment from Debiopharm Group™ and the appointment of a new CEO
January 8, 2014
LAUSANNE, Switzerland -- Spinomix SA, a Swiss company advancing molecular diagnostic through innovative sample preparation technologies and Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the successful achievement of a second development milestone on Spinomix' two proprietary technologies, namely [...]
January 8, 2014
MADISON, WIS. – Cellular Dynamics International (CDI; Nasdaq: ICEL) today announced signing a long-term supply agreement with the Nestlé Institute of Health Sciences SA (NIHS).Terms of the agreement were not disclosed. CDI’s iCell® product line includes cardiomyocytes, neurons, hepatocytes, and endothelial cells, with numerous other cell types in development. The company’s MyCell® Products are cell [...]
January 8, 2014
Houston, TX., USA –– PAC, a leading global provider of advanced analytical instruments for laboratories and online process applications, recently launched a new extended option for Cambridge Viscosity VISCOlab PVT, a high pressure viscometer for oil, gas and supercritical fluids. With the addition of higher rated valves, tubing, and materials, the VISCOlab PVT can now [...]
January 8, 2014
TESCAN, building on the success of its TIMA scanning electron microscope mineralogy analyzer, announced today the introduction of the TIMA with the Automated Loading System (AutoLoader). The TIMA equipped with AutoLoader is the first fully automated mineral analyzer to permit robust, continuous and unattended sample loading. This newly pioneered design delivers unprecedented high throughput analysis, [...]
Oracle Health Sciences Translational Research Center 3.0 Helps Advance Personalized Medicine
January 7, 2014
Redwood Shores, Calif. – Clinical researchers are focused on advancing the secondary use of medical data across clinical and research organizations to unlock the true potential of personalized medicine. To support this goal, the latest release of Oracle Health Sciences Translational Research Center features expanded omics and clinical data models, new user interfaces and workflows [...]
Acquisition propels the Company to being a major player in the NGS sample prep market
January 7, 2014
FREMONT, Calif. — WaferGen Bio-systems, Inc. (QTCQB: WGBS) announced today the acquisition of the NGS library preparation business from IntegenX Inc. Pursuant to the asset purchase agreement, WaferGen Bio-systems, Inc., through Wafergen, Inc., its wholly owned subsidiary, acquired on January 6, 2014 substantially all of the assets of IntegenX’s product line used in connection with [...]

